1、1Release date:2025.5.9?/?20242?.2I.?.3II.?4III.?.401:?.502:?.903:DCT?.2004:DCT?.2805:DCT?.35?.41?:?研?研?.44?a:?DCT?.44?b:?.45?c:?.46?d:?.46?e:?模?.46?f:?.46?g:?.46?h:?务?.46?i:?.46?.47?/?3?务?DCT?FDA?务?NMPA?纸?Vayena,2023?DCT?务?告?务?/?务?DCT?尽?务?CMAC?2024?务?DCT?2024?务?DCT?(?2024-Y-Y-007)?DCT?筛?确?2023?2024?

2、务?DCT?DCT?2025?1?25?995?11.9%?导?务?务57.4%?纸?/?15.8%?CRO?13.6%?尽?500?10,000?副?DCT?DCT?副?告?DCT?DCT?2024?81.9?14.8%?CAGR?2032?249.7?Business ResearchInsights,2025?够?务?务?务?尽?尽?务?尽?务?尽?尽?(副?)?尽?尽?务?CMAC)?/?4?2024?12?24?-2025?1?25?995?989?2023?11.9%?12?71?262?CRO24?SMO18?DCT?10?2024?务?DCT?2024?12?24?2025?1

3、?25?989?12?模?DCT?71?尽?262?纸?/?24?CRO?18?SMO?10?DCT?DCT?Industry Standard Research,2021?研?DCT?/?5?016?去?2024?纸?/?57.4%?2023?55.9%?2024?尽?13.7%?CRO?15.8%?务CRO?2023?18.9%?SMO?9.7%?DCT?1.9%?导?500?29.9%?副?36.5%?务?1,000-5,000?副?2024?25.4%?2023?16.8%?5,000?副?2023?37.19%?2024?34.7%?2024?纸?/?务?N=421?2023?59.

4、23%?61.8%?3.1%?6.2%?0.7%?去?2024?19.7%?务?/?56856857.4%13513513.7%15615615.8%96969.7%19191.9%15151.5%?/?CROSMODCT?其他12612629.9%424210.0%10710725.4%666615.7%808019.0%?尽?尽?500?500?1,000?1,0005,000?5,00010,000?10,000?26026061.8%838319.7%26266.2%21215.0%13133.1%10102.4%5 1.2%3 0.7%?尽?尽?研?信息技术IT统计药物警戒7?纸?/

5、?94.0%?2023?94.8%?务?纸?纸?副?务?务?12%?8.5%?7.6%?资?/?53453494.0%20203.5%5 50.9%9 91.6%纸?纸?/?纸?纸?/?8?2024?纸?55.1%?32.6%?7.7%?7.9%?4.8%?2023?研?务?DCT?告?务?导?务?资?务?的?DCT?的?纸?/?31331355.1%44447.7%18518532.6%26264.6%?9?0210?务?DCT?副?2023?务?28.8%?务?务?2024?副?37.4%?8.6%?的?务?副?DCT?筛?够?的?务?务?/?28.8%37.4%?DCTDCT?5?DCT

6、?/?11?eCOA/ePRO/eDiary?eCOA/ePRO/eDiary?2023?19.3%?副?2024?29.3%?务?研?16.6%?20.5%?研?2023?12.9%副?2024?16.8%?DCT?研?EDC?2023?7.1%副?2024?11.3%?研?11.4%?副?12.8%?告?(DHT)?5.7%副?9.7%?eCOA/ePRO/eDiary?副?8.9%?研?EDC?研?(DHT)?2023?50%?研?导?务?研?DCT?务?DCT?务?的?DCT?/?DCT?a?5?DCT?/?DCT?12?模?务?务?研?匹?Van Norman,2021?DCT?模?